$633 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 20 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 23.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TSRO | Buy | TESARO INC | $147,214,000 | -6.3% | 1,052,579 | +3.0% | 23.26% | -5.1% |
| AXK | New | ACCELERATE DIAGNOSTICS INC | $129,079,000 | – | 4,719,526 | +100.0% | 20.39% | – |
| MZOR | Sell | MAZOR ROBOTICS LTDsponsored ads | $85,460,000 | +5.9% | 2,471,378 | -8.9% | 13.50% | +7.3% |
| QDEL | Buy | QUIDEL CORP | $68,598,000 | +20.4% | 2,527,554 | +0.4% | 10.84% | +22.0% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $57,062,000 | -21.9% | 2,276,106 | -16.4% | 9.02% | -20.8% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $29,403,000 | +3.3% | 8,259,380 | +50.0% | 4.64% | +4.6% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $25,890,000 | +20.3% | 6,424,356 | -4.5% | 4.09% | +21.9% |
| OPK | Buy | OPKO HEALTH INC | $23,930,000 | -15.3% | 3,636,760 | +2.9% | 3.78% | -14.2% |
| VRML | VERMILLION INC | $17,005,000 | -12.0% | 9,241,956 | 0.0% | 2.69% | -10.8% | |
| XON | Sell | INTREXON CORP | $16,598,000 | +20.5% | 689,002 | -0.8% | 2.62% | +22.1% |
| BIOL | BIOLASE INC | $14,183,000 | -28.2% | 14,622,050 | 0.0% | 2.24% | -27.2% | |
| AGEN | New | AGENUS INC | $6,246,000 | – | 1,597,392 | +100.0% | 0.99% | – |
| EPZM | Sell | EPIZYME INC | $4,415,000 | -50.2% | 292,380 | -43.4% | 0.70% | -49.5% |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INCcall | $1,974,000 | +315.6% | 372,900 | +272.9% | 0.31% | +321.6% |
| BIIB | BIOGEN INC | $1,728,000 | -0.7% | 6,368 | 0.0% | 0.27% | +0.7% | |
| CFRX | CONTRAFECT CORP | $1,714,000 | -19.5% | 1,182,032 | 0.0% | 0.27% | -18.4% | |
| NXTM | Buy | NXSTAGE MEDICAL INCcall | $1,469,000 | +7245.0% | 460,800 | +360.8% | 0.23% | +7633.3% |
| TSRO | Buy | TESARO INCcall | $814,000 | -48.6% | 476,400 | +36.1% | 0.13% | -47.8% |
| AQB | AQUABOUNTY TECHNOLOGIES INC | $98,000 | -27.4% | 12,204 | 0.0% | 0.02% | -28.6% | |
| EYES | SECOND SIGHT MED PRODS INC | $64,000 | +4.9% | 50,804 | 0.0% | 0.01% | 0.0% | |
| AGEN | Exit | AGENUS INC | $0 | – | -1,709,379 | -100.0% | -1.00% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -1,418,194 | -100.0% | -1.05% | – |
| AXDX | Exit | ACCELERATE DIAGNOSTICS INC | $0 | – | -4,719,526 | -100.0% | -17.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.